Where the data comes from.
Every claim on every medication page links back to one of the sources catalogued below. They are grouped by tier of authority: Tier 1 is drug-level information from the Therapeutic Goods Administration and the World Health Organization; Tier 2 is the Commonwealth NDIS and clinical-quality framework; Tier 3 is the state and territory statutes and authorities that operate the authorisation regime on the ground; Tier 4 is a fallback for the handful of substances that none of the higher tiers cover. See How it works for a fuller account of how those tiers feed into the page.
Tier 1 — Drug-level (TGA + WHO)
The most authoritative tier. Substance-specific information drawn directly from the regulator's product-information document or the WHO classification index.
- TGA Product Information (PI) ↗
Mechanism, half-life, indications, contraindications, adverse effects. Per-medicine, fetched live from the TGA's eBS database.
- WHO ATC/DDD Index ↗
Substance class and ATC code. Hosted by the Norwegian Institute of Public Health on behalf of the WHO Collaborating Centre.
- TGA Poisons Standard (SUSMP) ↗
Schedule classification (S2/S3/S4/S8). Resolved live to the current in-force compilation.
Tier 2 — Commonwealth NDIS framework
The federal regulatory and clinical-quality framework that defines what a regulated restrictive practice is and how it must be managed.
- Pharmaceutical Benefits Scheme (PBS) ↗
PBS-subsidised indications and clinical criteria.
- NDIS Quality and Safeguards Commission — Behaviour support and restrictive practices ↗
The regulator's BSP-facing landing page for the regulated-restrictive-practices framework.
- NDIS (Restrictive Practices and Behaviour Support) Rules 2018 ↗
The operational rules made under the NDIS Act that define regulated restrictive practices and the Behaviour Support Plan requirements.
- National Disability Insurance Scheme Act 2013 ↗
The parent statute under which the NDIS Rules are made and the Quality and Safeguards Commission operates.
- ACSQHC Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard (2024) ↗
Clinical-quality standard from the Australian Commission on Safety and Quality in Health Care; eight quality statements for psychotropic prescribing in cognitive disability.
Tier 3 — State Senior Practitioner authorities
One per Australian state and territory. Each runs the day-to-day authorisation framework for restrictive practices in disability services.
- Office of the Senior Practitioner (Victoria) ↗
VIC restrictive-practice authorisation framework under the Disability Act 2006.
- NSW Department of Communities and Justice — Restrictive Practices Authorisation ↗
NSW restrictive-practice authorisation policy.
- Queensland Office of the Public Guardian ↗
QLD substitute decision-making and restrictive-practice consent regime under the Guardianship and Administration Act 2000 (Qld).
- Queensland Department of Families, Seniors, Disability Services and Child Safety ↗
QLD restrictive-practice oversight under the Disability Services Act 2006 (Qld).
- ACT Office of the Senior Practitioner ↗
ACT restrictive-practice authorisation under the Senior Practitioner Act 2018 (ACT).
- South Australia — Restrictive Practices Authorisation Scheme ↗
SA scheme under the Disability Inclusion Act 2018 (SA).
- WA Department of Communities — Authorisation of Restrictive Practices ↗
WA Quality Assurance Panel pathway.
- Tasmanian Senior Practitioner (Disability) ↗
TAS scheme under the Disability Rights, Inclusion and Safeguarding Act 2024 (Tas).
- Northern Territory NDIS Restrictive Practices Authorisation ↗
NT operates under federal NDIS Rules with state-level coordination via the Department of Territory Families.
Tier 3 — State legislation
The statutes that establish each state's restrictive-practice framework. Cited alongside the corresponding Senior Practitioner authority where one exists.
- Disability Act 2006 (Vic) ↗
Establishes the Victorian Senior Practitioner role and the regulated-restrictive-practice authorisation framework.
- Disability Services Act 2006 (Qld) ↗
Queensland disability-services restrictive-practice oversight.
- Guardianship and Administration Act 2000 (Qld) ↗
Queensland substitute-decision-making and consent framework.
- Senior Practitioner Act 2018 (ACT) ↗
ACT statutory basis for the Senior Practitioner role.
- Disability Inclusion Act 2018 (SA) ↗
South Australian disability framework.
- Disability Rights, Inclusion and Safeguarding Act 2024 (Tas) ↗
Tasmania's current restrictive-practice statute.
Tier 4 — Fallback
Used only when none of the higher tiers have content for a substance — typically supplements and over-the-counter medicines that don't appear in the TGA Product Information register.
- Wikipedia ↗
Tier 4 fallback used only for substances without TGA Product Information — vitamins, supplements, some over-the-counter medicines. Content is licensed CC-BY-SA; the citation chip on each claim links back to the source article.
Want a source added?
New authoritative sources are added when they are both audience-relevant for Behaviour Support Practitioners and have stable, citable URLs. The current register covers the standing chemical-restraint decision-making frame; the Mental Health Acts and Guardianship Acts that apply more broadly to substitute decision-making across all states are a deferred parallel-regime addition, scoped but not yet integrated.